Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R21 - Clinical Trial Optional)
HHS-NIH11
POSTED: 10/17/2024
UPDATED: 10/17/2024
DUE: 11/16/2025
The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications focused on the neurological and/or mental health-related manifestations of infection-associated chronic illnesses, i...
Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R01 - Clinical Trial Optional)
HHS-NIH11
POSTED: 10/17/2024
UPDATED: 10/17/2024
DUE: 11/05/2025
The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications focused on the neurological and/or mental health-related manifestations of infection-associated chronic illnesses, i...
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 10/15/2024
UPDATED: 10/15/2024
DUE: 10/14/2026
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications to support the validation of molecular/cellular/imaging markers (referred to as "markers" or...
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
HHS-NIH11
POSTED: 10/15/2024
UPDATED: 10/15/2024
DUE: 10/14/2026
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to accelerate the adoption and validation of molecular/cellular/imaging markers (referred to as "markers"...
Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)
HHS-NIH11
POSTED: 10/15/2024
UPDATED: 03/31/2025
DUE: 07/14/2026
This notice of funding opportunity (NOFO), utilizing the U24 grant funding mechanism, encourages applications for a collaborating Data Coordinating Center (DCC) application that accompanies an investi...
Emerging Global Leader Award (K43 Independent Clinical Trial Required)
HHS-NIH11
POSTED: 10/15/2024
UPDATED: 10/15/2024
DUE: 12/03/2026
This is a reissue of the Emerging Global Leader Program (K43) to align with the clinical trials policy.
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 10/15/2024
UPDATED: 10/15/2024
DUE: 12/03/2026
This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, ...
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
HHS-NIH11
POSTED: 10/12/2021
UPDATED: 04/02/2025
DUE: 01/07/2026
This Funding Opportunity Announcement (FOA) invites applications for P30 Cancer Center Support Grants (CCSGs) to support NCI-designated Cancer Centers. CCSGs support three types of Cancer Centers: 1) ...
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 10/10/2024
UPDATED: 10/10/2024
DUE: 10/14/2026
Through this Notice of Funding Opportunity (NOFO) is to accelerate the pace of translation of NCI-supported methods/assays/technologies (referred to as "assays") to the clinic. Specifically, the focus...
Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)
HHS-NIH11
POSTED: 10/10/2024
UPDATED: 10/10/2024
DUE: 01/06/2028
To support competing renewal or competitive revision of ongoing clinical trials supported by the National Institute of Dental and Craniofacial Research (NIDCR)